DR 800 with MUSICA Dynamic
Agfa HealthCare N.V. • Radiology • 04/05/2018
Device Purpose
The Agfa HealthCare DR 800 is an image-intensified fluoroscopic x-ray system designed for a broad spectrum of dynamic and static radiographic imaging procedures, incorporating MUSICA Dynamic™ image processing and flat-panel detectors for digital image acquisition and enhanced diagnostic capabilities. The system's methodology centers on replacing traditional fluoroscopic components with advanced digital capture and image processing algorithms, validated through bench testing to ensure image quality, usability, and dose optimization, particularly for general and pediatric applications.
Summary
The Agfa HealthCare DR 800 with MUSICA Dynamic™ is an image-intensified fluoroscopic x-ray system designed to capture images of the human body for a variety of diagnostic procedures. Its applications include positioning fluoroscopy, gastro-intestinal and urogenital tract examinations, angiography, and general project radiography of all body parts, excluding mammography. The system is a floor-mounted R/F unit comprising a tube, operator console, motorized tilting patient table, and bucky, with options for a wall stand, Full Leg Full Spine (FLFS) overlay, and ceiling suspension. It employs Agfa’s NX workstation integrated with MUSICA Dynamic™ image processing software and flat-panel detectors, enabling digital and wide dynamic range image capture. This technology is intended to replace older direct radiography systems, image intensifying tubes, TV cameras, and computed radiography systems with conventional or phosphorous film cassettes. The DR 800's performance was evaluated through extensive laboratory and software testing, without the conduct of clinical trials or animal studies. Image quality evaluations were conducted by independent radiologists using anthropomorphic phantoms, confirming that pulsed and continuous fluoroscopy imaging with MUSICA Dynamic was between good and excellent, and MUSICA3 Abdomen+ images were suitable for diagnosis; static images made with the R/F flat-panel detector were also found clinically acceptable. Usability and functionality assessments with radiographers led to system improvements. Full Leg Full Spine (FLFS) clinical validation confirmed the system met acceptance criteria for image stitching and related functionalities. Dose control validation using adult and pediatric phantoms demonstrated that detector doses remained within established safety limits. Software verification and validation confirmed the system meets performance, safety, usability, and security requirements, with a moderate level of concern for the software where benefits are assumed to outweigh residual risks.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the MUSICA Dynamic image processing algorithm specifically enhance image quality for pediatric patients compared to adult patients, considering different tissue densities and radiation sensitivities?; What are the quantitative differences in diagnostic performance or image acquisition workflow efficiency when using the DR 800 with MUSICA Dynamic for complex procedures like angiography, compared to systems employing only MUSICA2 or the predicate's ATS software?; Beyond the stated Full Leg Full Spine (FLFS) validation for mount stitch grid and imaging ranges, what specific technical improvements in the NX Luna FLFS software contribute to minimizing artifacts and enhancing measurement accuracy in stitched images?; Could the dose control validation data, particularly for pulsed fluoroscopy, be used to establish optimized, indication-specific protocols within the NX workstation to further reduce radiation exposure for vulnerable patient populations?; Given the 'moderate' level of concern and the 26 risks in the ALARP region for the NX4.0 software, what are the three most significant identified risks related to image processing or system control, and what are their corresponding mitigation strategies implemented in the DR 800?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, HBOM, VDR/VEX detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, SaaSBOM, CBOM, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly